Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity.
Tekincan Çağrı AktaşDeniz KızmazoğluSafiye AktaşÖzde Elif GökbayrakEfe SerinanAylin ErolZekiye AltunHongling YuanHatice Nur OlgunPublished in: Technology in cancer research & treatment (2023)
We found that F1174 and R1275Q-related anaplastic lymphoma kinase mutations are the most common pathogenic mutations in neuroblastoma. Anaplastic lymphoma kinase mutation status did not show any heterogeneity, and the mutations were correlated with intermediate- or high-risk groups.